Control of Ozempic Distribution to Diabetics Only
August 1, 2025
The Health Insurance Organization is conducting a strict review of the beneficiaries receiving Ozempic, limiting its administration exclusively to diabetics. Doctors are requested to submit patient requests by August 2025. This decision was made due to the misuse of the drug by individuals seeking weight loss. Aimed at protecting genuine patients, the Organization is establishing strict procedures for prescribing.